CLINICAL_TRIALS trial_result · 2023-07-17

Clinical Trial Update: NAD+ Precursor Supplementation in Friedreich's Ataxia [Phase 2]

Phase 2 clinical trial of NAD+ precursor supplementation in Friedreich's ataxia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Metro International Biotech, LLC | Conditions: Friedreich Ataxia | Phase 2 | Status: COMPLETED | Results posted: 2023-07-17